Want to see PTGX full AI Analyst Report?
Protagonist Therapeutics (PTGX) Ownership Overview
1.18% Insiders
29.88% Mutual Funds
4.40% Other Institutional Investors
28.31% ETFs
36.22% Public Companies and
Individual Investors
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 62.60% of the company’s stock is owned by Institutional Investors, 1.18% is owned by Insiders, and 36.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 10, 2026 | xxxxxxxxxxxxx | $18240568 | |
Aug 12, 2026 | xxxxxxxxxxxxx | $14890799 | |
Jun 25, 2026 | xxxxxxxxxxxxx | $1061460 | |
Jun 11, 2026 | xxxxxxxxxxxxx | $969120 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $120358728 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $89612477 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $25606962 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $20902832 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,596,760 | Institution | 11.74% | 1,100,390,686 | |
| 6,348,906 | Institution | 9.81% | 919,639,034 | |
| 6,054,824 | Institution | 9.36% | 877,041,256 | |
| 5,063,728 | Institution | 7.83% | 733,481,001 | |
| 2,260,715 | Institution | 3.49% | 327,464,568 | |
| 1,414,173 | Institution | 2.19% | 204,842,959 | |
| 1,243,618 | Institution | 1.92% | 180,138,067 | |
| 981,879 | Institution | 1.52% | 142,225,173 | |
| 971,779 | Institution | 1.50% | 140,762,188 | |
| 918,952 | Institution | 1.42% | 133,110,197 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,063,728 | Institution | 7.83% | 733,481,001 | |
| 1,243,618 | Institution | 1.92% | 180,138,067 | |
| 971,779 | Institution | 1.50% | 140,762,188 | |
| 918,952 | Institution | 1.42% | 133,110,197 | |
| 881,156 | Institution | 1.36% | 127,635,447 | |
| 828,559 | Institution | 1.28% | 120,016,771 | |
| 607,713 | Institution | 0.94% | 88,027,228 | |
| 600,072 | Institution | 0.93% | 86,920,429 | |
| 455,742 | Institution | 0.70% | 66,014,229 | |
| 437,518 | Institution | 0.68% | 63,374,482 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,875,863 | Institution | 5.99% | 550,915,167 | |
| 2,049,500 | Institution | 3.17% | 288,754,055 | |
| 1,557,431 | Institution | 2.41% | 221,373,242 | |
| 1,455,881 | Institution | 2.25% | 205,119,074 | |
| 1,067,484 | Institution | 1.65% | 151,732,176 | |
| 811,164 | Institution | 1.25% | 114,284,896 | |
| 729,378 | Institution | 1.13% | 102,762,066 | |
| 591,597 | Institution | 0.91% | 84,089,598 | |
| 584,267 | Institution | 0.90% | 84,333,099 | |
| 580,311 | Institution | 0.90% | 83,762,090 |
FAQ
Who Owns Protagonist Therapeutics (PTGX)?
According to the latest TipRanks data, approximately 4.40% of the company's stock is held by institutional investors, 1.18% is held by insiders, and 36.22% is held by retail investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.40% of Protagonist Therapeutics (PTGX) stock is held by institutional investors.
What percentage of Protagonist Therapeutics (PTGX) stock is held by retail investors?
According to the latest TipRanks data, approximately 36.22% of Protagonist Therapeutics (PTGX) stock is held by retail investors.
Who owns the most shares of Protagonist Therapeutics (PTGX)?
iShares owns the most shares of Protagonist Therapeutics (PTGX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.